Print Page | Contact Us | Sign In | Register
Online Store: DCMS Store Products
Main Storefront

CME: Management of Metastatic Breast Cancer

Item Options
Price: $55.00
Quantity: *

After purchasing this CME Certification, you will receive a PDF download in your email containing the article and the evaluation. If you do not receive it, please check your spam box or contact


The article, “Progress in the Management of Metastatic Breast Cancer in 2018: Is a Cure in the Horizon?” authored by Gerardo Colón-Otero, MD, has been approved for 1 AMA PRA Category 1 credit.TM

Gerardo Colón-Otero, MD, Professor of Medicine, Mayo Clinic College of Medicine, Vice-Dean, Mayo Clinic School of Medicine, Dean, Florida Campus, Mayo Clinic School of Medicine.


1.) List the drugs approved over the last six years for the treatment of metastatic breast cancer.

2.) Describe the biomarkers used for the selection of treatments for patients with metastatic breast cancer.

3.) State the names of promising new drugs currently being evaluated for the management of metastatic breast cancer.

Date of Release: Oct. 1, 2018

Date Credit Expires: Oct. 1, 2020

CME Credit Eligibility:
A minimum passing grade of 70% must be achieved. Only one re-take opportunity will be granted. 

Faculty Disclosure:

Gerardo Colón-Otero, MD reports grant/research support from Novartis to Mayo Clinic for Investigator Initiated Trial.

Disclosure of Conflicts of Interest:
St. Vincent’s Healthcare (SVHC) requires speakers, faculty, CME Committee and other individuals who are in a position to control the content of this educations activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by SVHC for fair balance, scientific objectivity of studies mentioned in the presentation and educational materials used as basis for content, and appropriateness of patient care recommendations. 

Joint Sponsorship Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of St. Vincent’s Healthcare and the Duval County Medical Society. St. Vincent’s Healthcare designates this educational activity for a maximum of 1 AMA PRA Category 1 credit.TM Physicians should only claim credit commensurate with the extent of their participation in the activity.